홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Phosgene → 1-(5-Tert-butyl-2-methoxy-phenyl)-3-(4-pyrrolo[3,2-c]pyridin-1-yl-naphthalen-1-yl)-urea

HRID 2417002
인쇄

반응식

HRID 2417002 반응식
[C:1]([C:5]1[CH:6]=[C:7]([NH2:13])[C:8](=[CH:11][CH:12]=1)[O:9][CH3:10])([CH3:4])([CH3:3])[CH3:2].[C:14]([O-:17])(O)=O.[Na+].C(Cl)(Cl)=O.[N-]=C=O.[NH2:26][C:27]1[C:36]2[C:31](=[CH:32][CH:33]=[CH:34][CH:35]=2)[C:30]([N:37]2[C:45]3[CH:44]=[CH:43][N:42]=[CH:41][C:40]=3[CH:39]=[CH:38]2)=[CH:29][CH:28]=1>ClCCl.C1COCC1>[C:1]([C:5]1[CH:12]=[CH:11][C:8]([O:9][CH3:10])=[C:7]([NH:13][C:14]([NH:26][C:27]2[C:36]3[C:31](=[CH:32][CH:33]=[CH:34][CH:35]=3)[C:30]([N:37]3[C:45]4[CH:44]=[CH:43][N:42]=[CH:41][C:40]=4[CH:39]=[CH:38]3)=[CH:29][CH:28]=2)=[O:17])[CH:6]=1)([CH3:4])([CH3:2])[CH3:3]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 6371PhosgeneHCID 105034IsocyanateHCID 516892Sodium BicarbonateHCID 41763185-tert-Butyl-o-anisidineHCID 114823371-(4-Aminonaphthalen-1-yl)pyrrolo[3,2-c]pyridine

생성물 1

HCID 101619341-(5-Tert-butyl-2-methoxy-phenyl)-3-(4-pyrrolo[3,2-c]pyridin-1-yl-naphthalen-1-yl)-urea

시약·촉매·용매 2

HCID 6344Dichloromethane용매HCID 8028Tetrahydrofuran용매

반응 조건

온도
0 °C

실험 절차

4-tert-Butyl-o-anisidine (54 mg, 0.301 mmol, 1 equiv.) was dissolved in 15 mL dichloromethane and 15 mL of saturated aqueous NaHCO3 solution was added. The biphasic mixture was cooled to 0° C. and phosgene (˜2 M solution in toluene, 0.75 mL) was added to the organic layer via syringe in one portion, without stirring. The mixture was then stirred vigorously for 10 min, then the layers were separated. The aqueous layer was extracted once with dichloromethane and the combined organics were dried (Na2SO4), filtered and most of the dichloromethane was removed in vacuo, leaving the toluene. To this isocyanate residue was then added 1-(4-aminonaphthalen-1-yl)pyrrolo[3,2-c]pyridine (Example 1) (77 mg, 0.297 mmol, 1 equiv.) dissolved in 5 mL anhydrous THF. The mixture was left to stir at room temperature for 2 h, then the solvents were removed in vacuo. The residue was purified by column chromatography on SiO2 using dichloromethane/MeOH eluent mixtures. The isolated enriched fraction was further purified by reverse-phase preparative HPLC to provide 20 mg of the title compound as a white foam.

후처리

  1. stirringThe mixture was then stirred vigorously for 10 min
  2. customthe layers were separated
  3. extractionThe aqueous layer was extracted once with dichloromethane
  4. dry with materialthe combined organics were dried (Na2SO4)
  5. filtrationfiltered and most of the dichloromethane
  6. customwas removed in vacuo
  7. customleaving the toluene
  8. waitThe mixture was left
  9. stirringto stir at room temperature for 2 h
  10. customthe solvents were removed in vacuo
  11. customThe residue was purified by column chromatography on SiO2
  12. customThe isolated enriched fraction was further purified by reverse-phase preparative HPLC

출처 및 근거

ORD 기록
ord-807c26baa05a4cc88a4b4549ad381f1c
출처 데이터셋
uspto-grants-2004_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06825184B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트